Lung Cancer Archives

Risk Models Help Select Ever Smokers for Lung Cancer Screening

Risk Models Help Select Ever Smokers for Lung Cancer Screening

Four models were well-calibrated and had higher areas under the curve than 5 models that overestimated lung cancer risk.

CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer

CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer

Serum CKAP4 levels of lung cancer patients were significantly higher than those of healthy controls.

Cancer Incidences and Burden Expected to Shift in HIV-Positive

Cancer Incidences and Burden Expected to Shift in HIV-Positive

Prostate and lung cancer expected to emerge as the most common types by 2030.

Clinical Upstaging of NSCLC Seen With Each Progressive Week

Clinical Upstaging of NSCLC Seen With Each Progressive Week

For clinical stage 1 non-small-cell lung cancer, 21.7% of patients upstaged after 1 week and 31.5% after 8 weeks.

Polypharmacy More Likely for Cancer Survivors

Polypharmacy More Likely for Cancer Survivors

More cancer survivors prescribed 5 or more unique medications, including medications with abuse potential.

A Potential Algorithm for Diagnosing Cavitary Lung Diseases

A Potential Algorithm for Diagnosing Cavitary Lung Diseases

Researchers developed an algorithmic approach to diagnosing lung cavitary diseases.

Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC

Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC

Nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden.

Most Patients Are Unaware of Cancer Drug Shortages

Most Patients Are Unaware of Cancer Drug Shortages

Majority of patients say they want to know about even minor consequences of cancer drug substitutions.

Dacomitinib Granted Priority Review for NSCLC With EGFR-Activating Mutations

Dacomitinib Granted Priority Review for NSCLC With EGFR-Activating Mutations

Dacomitinib is a pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.

Lag in Progress Against Lung Cancer Mortality in Midwest, Appalachia

Lag in Progress Against Lung Cancer Mortality in Midwest, Appalachia

Findings based on rates in women vs steady decline seen nationally.

Benign Lung Nodules Identified Using Proteomic Biomarker

Benign Lung Nodules Identified Using Proteomic Biomarker

An integrated proteomic classifier accurately identified benign lung nodules when used in patients with a pretest probability of malignancy ≤50%.

Lung Cancer Risk May Be Predicted by Frequency of COPD Exacerbations

Lung Cancer Risk May Be Predicted by Frequency of COPD Exacerbations

Independent predictive factors of lung cancer in chronic obstructive pulmonary disease may include frequency of exacerbations, in addition to airflow obstruction and visual emphysema.

COPD, Respiratory Symptoms Associated With "Western" Diet

COPD, Respiratory Symptoms Associated With "Western" Diet

Researchers used data from the Atherosclerosis Risk in Communities Study to assess associations between dietary pattern and pulmonary assessments.

Infused Chemotherapy Trends During 10-Year Period

Infused Chemotherapy Trends During 10-Year Period

During a 10-year period, there was an increase in the rate of commercially insured patients receiving infused chemotherapy in hospital outpatient departments.

Exercise May Improve Quality of Life in Lung Cancer

Exercise May Improve Quality of Life in Lung Cancer

Study examines increased physical activity may lower the risk for several cancers and may be beneficial for improving quality of life.

Lung Cancer Screening: Updated Guidelines From CHEST

Lung Cancer Screening: Updated Guidelines From CHEST

A CHEST expert panel has released updated guidelines for lung cancer screening.

Lung Cancer Postoperative Complications Reduced With Preoperative Exercise

Lung Cancer Postoperative Complications Reduced With Preoperative Exercise

Patients who underwent lung resections had reduced postoperative complication rates when they participated in preoperative exercise.

Early-Stage Non-Small Cell Lung Cancer Mortality With Surgery vs Radiotherapy

Early-Stage Non-Small Cell Lung Cancer Mortality With Surgery vs Radiotherapy

Mortality rates are higher after surgery vs stereotactic body radiotherapy for patients with early non-small-cell lung cancer.

Lung Cancer Screening Requires Effective Risk Stratification

Lung Cancer Screening Requires Effective Risk Stratification

Lung cancer screening is more effective and efficient for high-risk individuals.

Lung Cancer Survival May Be Predicted by BMI and Age

Lung Cancer Survival May Be Predicted by BMI and Age

Younger age and higher body mass index may be positive predictors of progression-free survival in patients with squamous cell carcinoma of the lung.

Small Cell Lung Cancer: Barriers to Chemotherapy, Radiation

Small Cell Lung Cancer: Barriers to Chemotherapy, Radiation

Lack of insurance correlated with a reduced likelihood of chemotherapy and radiation therapy for small cell lung cancer.

Lack of Communication Regarding Malignancy Risk in Indeterminate Pulmonary Nodules

Lack of Communication Regarding Malignancy Risk in Indeterminate Pulmonary Nodules

Qualitative risk statements of malignancy for indeterminate pulmonary nodules are imprecise, highly variable, and should be replaced by a standard scale.

Current Cancer Death Rates in the United States

Current Cancer Death Rates in the United States

The cancer death rate declined by 1.5% annually from 2006 to 2015 in the United States.

Lung Cancer Screening by CT Scan: Risk-Based vs USPSTF Criteria

Lung Cancer Screening by CT Scan: Risk-Based vs USPSTF Criteria

Lung cancer screening based on USPSTF criteria decreased from 2010 to 2015 while risk-targeted screening is associated with modest gains in terms of early lung cancer mortality per person screened.

Measuring Immuno-Oncology Agents Against Cancer Care Framework

Measuring Immuno-Oncology Agents Against Cancer Care Framework

Few modern, US FDA-approved immuno-oncology agents have durable survival and response rates that are deemed significant by the ASCO value framework.

Treatment Disparities in Elderly Patients With Non-Small Cell Lung Cancer

Treatment Disparities in Elderly Patients With Non-Small Cell Lung Cancer

Many octogenarians and nonagenarians with non-small cell lung cancer do not receive cancer-directed care.

Thromboembolic Event Risk With Cisplatin vs Carboplatin in Lung Cancer

Thromboembolic Event Risk With Cisplatin vs Carboplatin in Lung Cancer

Platinum-based chemotherapy agents for lung cancer may increase the risk for thromboembolism.

Chemotherapy Followed by Radiotherapy Improves Survival in NSCLC

Chemotherapy Followed by Radiotherapy Improves Survival in NSCLC

Adjuvant chemotherapy administered prior to, rather than concurrently with, radiotherapy improves survival outcomes among patients with NSCLC.

Lung Cancer Risk Reduced With Smoke-Free Ordinances

Lung Cancer Risk Reduced With Smoke-Free Ordinances

Few cases of lung cancer suspected in counties with smoke-free ordinances.

Cancer Survival Varies by Type of Health Insurance

Cancer Survival Varies by Type of Health Insurance

Improvements in cancer survival were limited to patients with private insurance, from 1997-2014.

Lung Cancer Has Highest Number of Preventable Cases, Deaths

Lung Cancer Has Highest Number of Preventable Cases, Deaths

An estimated 42.0% of all incident cancers and 45.1% of cancer deaths in the United States are attributed to potentially modifiable risk factors.

Lobectomy vs Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer

Lobectomy vs Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer

Survival is better with lobectomy than SBRT in patients with NSCLC.

Cancer-Related Fatigue May Benefit From Acupuncture

Cancer-Related Fatigue May Benefit From Acupuncture

More than 50% of patients report experiencing cancer-related fatigue throughout the disease process.

Traits for High-Value Oncology Practices Identified

Traits for High-Value Oncology Practices Identified

Three of 13 attributes identified had the highest potential for reduced spending without compromising care.

Liquid Biopsy May Be a Noninvasive Measure for Treatment Response in NSCLC

Liquid Biopsy May Be a Noninvasive Measure for Treatment Response in NSCLC

Patients with PD-L1-positive malignancies have shown higher response rates to immune checkpoint inhibition and consequently prolonged progression-free/overall survival compared with others.

Osimertinib May Improve Outcomes in EGFR Mutation-Postive NSCLC

Osimertinib May Improve Outcomes in EGFR Mutation-Postive NSCLC

Treatment with osimertinib is associated with longer progression-free survival in patients with previously untreated EGFR mutation-positive advanced non-small-cell lung cancer.

Non-Small Cell Lung Cancer: Trends in Stage I Treatment

Non-Small Cell Lung Cancer: Trends in Stage I Treatment

Between 2000 and 2010, researchers identified a decline in the number of patients with stage I NSCLC who remained untreated.

Non-Small Cell Lung Cancer: Nivolumab vs Docetaxel for Long-Term Efficacy

Non-Small Cell Lung Cancer: Nivolumab vs Docetaxel for Long-Term Efficacy

Results of two phase 3 studies found that nivolumab provided superior overall survival vs docetaxel in people with non-small cell lung cancer.

Small Cell Lung Cancer Survival With Anticoagulant Therapy

Small Cell Lung Cancer Survival With Anticoagulant Therapy

Trial results provided strong evidence against the use of anticoagulant low molecular weight heparin in SCLC.

Anti-Inflammatory Therapy With Canakinumab May Reduce Lung Cancer Rates

Anti-Inflammatory Therapy With Canakinumab May Reduce Lung Cancer Rates

Patients with lung cancer and atherosclerosis diagnosis may benefit from anti-inflammatory therapy with canakinumab.

Quality of Life Benefits of Yoga in Non-Small Cell Lung Cancer

Quality of Life Benefits of Yoga in Non-Small Cell Lung Cancer

Patients with NSCLC experienced improvements in both function and quality of life with yoga therapy.

Potential Delays in Non-Small Cell Lung Cancer Therapy

Potential Delays in Non-Small Cell Lung Cancer Therapy

Study results stress the importance of a multiethnic support system for patients needing to overcome communication barriers.

New "Pan-Can" Model More Accurately Predicts Lung Cancer Risk

New "Pan-Can" Model More Accurately Predicts Lung Cancer Risk

PanCan study effectively identified patients who eventually developed early-stage lung cancer, compared to other predictive models.

Updated Lung Cancer Screening Guidelines Released at CHEST

Updated Lung Cancer Screening Guidelines Released at CHEST

The ACCP just released new lung cancer screening guidelines.

Lung Cancer Screening Endorsed by Pulmonary and Primary Care Providers

Lung Cancer Screening Endorsed by Pulmonary and Primary Care Providers

Researchers surveyed knowledge, beliefs, attitudes, barriers, and facilitators related to screening patients for lung cancer.

Small-cell Lung Cancer Benefits From Maintenance Therapy With Pazopanib

Small-cell Lung Cancer Benefits From Maintenance Therapy With Pazopanib

Pazopanib improves progression-free survival in patients with small-cell lung cancer.

Gefitinib Treatment Should Be Avoided Prior to Chemotherapy in Non-small Cell Lung Cancer

Gefitinib Treatment Should Be Avoided Prior to Chemotherapy in Non-small Cell Lung Cancer

First generation EGFR tyrosine kinase inhibitors should be used in combination with chemotherapy if a patient has progressive EGFR mutation-positive non-small cell lung cancer.

Dacomitinib vs Gefitinib for Progression-Free Survival in Non-small Cell Lung Cancer

Dacomitinib vs Gefitinib for Progression-Free Survival in Non-small Cell Lung Cancer

Dacomitinib improved progression-free survival in patients with non-small cell lung cancer.

Case Report: Small Cell Lung Cancer Case With Tumor Lysis Syndrome

Case Report: Small Cell Lung Cancer Case With Tumor Lysis Syndrome

Tumor lysis syndrome can occur even in the absence of chemotherapy, and clinicians should remain suspicious when patients demonstrate laboratory abnormalities.

Greater Depth of Response to Therapy Improves Survival in Non-small Cell Lung Cancer

Greater Depth of Response to Therapy Improves Survival in Non-small Cell Lung Cancer

Overall and progression-free survival were improved with greater depth of response to therapy in non-small cell lung cancer.

Thoracic Radiotherapy Does Not Increase Risk for Immune-Related AEs in Lung Cancer

Thoracic Radiotherapy Does Not Increase Risk for Immune-Related AEs in Lung Cancer

Patients with metastatic lung cancer who receive both both immune checkpoint inhibitors and thoracic radiotherapy.do not have a greater risk for immune-related adverse events.

Non-small Cell Lung Cancer Survival Improved With Adoptive Cellular Immunotherapy

Non-small Cell Lung Cancer Survival Improved With Adoptive Cellular Immunotherapy

Adjuvant adoptive cellular immunotherapy plus chemotherapy improved survival in patients with resected non-small cell lung caner.

Non-small Cell Lung Cancer Staging Accuracy Tied to Nodal Examination

Non-small Cell Lung Cancer Staging Accuracy Tied to Nodal Examination

Thoroughness of nodal examination determines prognostic value of non-small cell lung cancer staging.

Non-small Cell Lung Cancer Metastasis at Diagnosis May Be Predicted by Genetic Mutations

Non-small Cell Lung Cancer Metastasis at Diagnosis May Be Predicted by Genetic Mutations

ROS1 and ALK rearrangements in patients with non-small cell lung cancer may predict different metastasis distributions at diagnosis.

Diagnostic Test Can Identify Biomarkers to Detect Lung Cancer

Diagnostic Test Can Identify Biomarkers to Detect Lung Cancer

A new diagnostic test and algorithm may be able to diagnose lung cancer from tumor-educated platelets.

Lung Cancer Is a Significant Cause of Death in Smokers Living With HIV

Lung Cancer Is a Significant Cause of Death in Smokers Living With HIV

Smokers with HIV who are adherent to antiretroviral therapy are still likely to die from lung cancer.

Standard vs High-Dose Chemoradiation in Stage 3 Non-Small Cell Lung Cancer

Standard vs High-Dose Chemoradiation in Stage 3 Non-Small Cell Lung Cancer

Higher doses of chemoradiation in stage 3 non-small cell lung cancer did not improve overall survival rates.

Impact of Canakinumab on Mortality, Incidence of Lung Cancer

Impact of Canakinumab on Mortality, Incidence of Lung Cancer

There may be a decreased rate of lung cancer for patients who receive anti-inflammatory therapy with canakinumab.

Durvalumab Linked to Longer Progression-Free Survival in NSCLC

Durvalumab Linked to Longer Progression-Free Survival in NSCLC

Fewer than 30% of patients undergoing durvalumab therapy experienced either grade 3 or 4 adverse events.

Does CT Scan at Follow-up Improve Resected NSCLC Survival?

Does CT Scan at Follow-up Improve Resected NSCLC Survival?

Recommendations to include CT scans as standard follow-up procedure is based on poor evidence.

FDA: Bevacizumab-awwb First Biosimilar Approved for Anticancer Therapy

FDA: Bevacizumab-awwb First Biosimilar Approved for Anticancer Therapy

Bevacizumab-awwb was approved based on pharmacokinetic and pharmacodynaic profiles and immunogenicity, safety, and efficacy data.

Does Targeted Inflammation Therapy Reduce Risk of CV Events, Lung Cancer?

Does Targeted Inflammation Therapy Reduce Risk of CV Events, Lung Cancer?

Canakinumab vs placebo showed promising results in preventing recurrent cardiovascular events and incidences of lung cancer.

Improving Anorexia-Cachexia in Non-small Cell Lung Cancer

Improving Anorexia-Cachexia in Non-small Cell Lung Cancer

Data from 5 phase 2/3 studies demonstrate improved weight and body mass in patients with NSCLC receiving anamorelin.

Improving Survival in Resected NSCLC With Adoptive Cellular Immunotherapy

Improving Survival in Resected NSCLC With Adoptive Cellular Immunotherapy

A phase 3 trial examined the efficacy of chemoimunnotherapy vs chemotherapy alone in postsurgical patients with non-small cell lung cancer.

Clinical Trial Eligibility Criteria: Barriers for People With Lung Cancer

Clinical Trial Eligibility Criteria: Barriers for People With Lung Cancer

A retrospective study of lung cancer clinical trials found that trials continue to increase their eligibility criteria, creating barriers to patient access.

FDA: Priority Review for Alectinib for ALK-positive NSCLC

FDA: Priority Review for Alectinib for ALK-positive NSCLC

Priority review for alectinib was granted based on evidence from the phase 3 ALEX and J-ALEX clinical trials.

FDA: Durvalumab Granted Breakthrough Therapy Designation for NSCLC

FDA: Durvalumab Granted Breakthrough Therapy Designation for NSCLC

Durvalumab can be used to treat patients with locally advanced, unrescetable NSCLC, who do not relapse after platinum-based chemoradiation.

Lung Cancer Screening CT Scans in High-Risk Smokers Increase Cessation Rates

Lung Cancer Screening CT Scans in High-Risk Smokers Increase Cessation Rates

Patients who underwent lung CT screening had a higher 2-week smoking cessation rate vs patients who did not undergo screening.

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Recent research suggests that perioperative and postoperative pulmonary rehabilitation improves outcomes in patients undergoing thoracic surgery.

Alternative vs Usual Tx Outcomes for Lung, Breast, Colorectal Cancers

Alternative vs Usual Tx Outcomes for Lung, Breast, Colorectal Cancers

Patients who underwent alternative therapies were more likely to die vs those who underwent usual care.

B Vitamin Supplementation Not Associated With Decreased Cancer Risk

B Vitamin Supplementation Not Associated With Decreased Cancer Risk

Men and male smokers were most impacted by the association between vitamin B6 and B12 supplementation and lung cancer risk.

Accuracy of Physician Estimates of Pulmonary Nodule Pretest Probability of Malignancy

Accuracy of Physician Estimates of Pulmonary Nodule Pretest Probability of Malignancy

Physicians can differentiate between benign and malignant pulmonary nodules, but do not consistently follow guideline-based recommendations when selecting the next diagnostic test.

Does Palifosfamide With Platinum Doublet Prolong SCLC Survival?

Does Palifosfamide With Platinum Doublet Prolong SCLC Survival?

Palifosfamide added to carboplatin and etoposide did not prolong survival among patients with extensive-stage small-cell lung cancer.

Incident Lung Cancer Associated With Total, Saturated Fat Consumption

Incident Lung Cancer Associated With Total, Saturated Fat Consumption

Over 18,000 cases of incident lung cancer were identified over mean 9.4 years of follow-up.

ASCO Releases Updated Guidelines for Antiemetics in Cancer Patients

ASCO Releases Updated Guidelines for Antiemetics in Cancer Patients

ASCO has released updated guidelines to help physicians manage nausea and vomiting caused by antineoplastic agents in cancer patients.

Caregiver vs Patient View of Functional Status in Older Cancer Patients

Caregiver vs Patient View of Functional Status in Older Cancer Patients

Caregivers often rate patients as having poorer functional status than patients rate themselves.

Predicting Overall Survival With Neutrophil-Lymphocyte Ratio in NSCLC

Predicting Overall Survival With Neutrophil-Lymphocyte Ratio in NSCLC

Valuable information regarding patients' life expectancy can be collected through neutrophil-lymphocyte ratio biomarkers.

Child Intelligence Scores Tied to Mortality Risk for CV, Respiratory, Digestive Diseases

Child Intelligence Scores Tied to Mortality Risk for CV, Respiratory, Digestive Diseases

Childhood intelligence scores are associated with lower risk of mortality caused by coronary heart disease, cancers related to smoking, respiratory diseases, digestive diseases, injury, and dementia.

Efficacy of Neoadjuvant Nivolumab in NSCLC

Efficacy of Neoadjuvant Nivolumab in NSCLC

Researchers considered the response rate "encouraging" and comparable to cisplatin-based neoadjuvant therapy outcomes.

Examining the Relationship Between Neurocognitive Function and QoL in Advanced Lung Cancer

Examining the Relationship Between Neurocognitive Function and QoL in Advanced Lung Cancer

Patients with metastatic lung cancer require careful considerations concerning quality of life.

9/11 First Responders Experiencing Higher Rates of Chronic Cardiovascular, Respiratory Diseases

9/11 First Responders Experiencing Higher Rates of Chronic Cardiovascular, Respiratory Diseases

Intense exposure over the course of a single day has been linked to an elevated risk of developing chronic health conditions.

Efficacy of Once- vs Twice-daily Ratiotherapy for SCLC With Concurrent Chemoradiotherapy

Efficacy of Once- vs Twice-daily Ratiotherapy for SCLC With Concurrent Chemoradiotherapy

The randomzied, phase 3 CONVERT trial examined 547 patients with small-cell lung cancer.

Treating Limited-stage Small-cell Lung Cancer With Proton-beam Tx

Treating Limited-stage Small-cell Lung Cancer With Proton-beam Tx

Results showed that proton-beam therapy in small-cell lung cancer can be safe in combined modality therapy.

Survival Outcomes With Nivolumab vs Chemotherapy for Stage IV, Recurrent NSCLC

Survival Outcomes With Nivolumab vs Chemotherapy for Stage IV, Recurrent NSCLC

Findings in patients with previously untreated disease with PD-L1 expression level of 5%.

Improving NSCLC Outcomes With Midtreatment FDG-PET-Driven Radiation Tx

Improving NSCLC Outcomes With Midtreatment FDG-PET-Driven Radiation Tx

Increased radiation therapy based on midtreatment residual tumor FDG-PET may improve local control among patients with advanced NSCLC.

Pack-Year Smoking History Best Elicited by Shared-Decision Making

Pack-Year Smoking History Best Elicited by Shared-Decision Making

Electronic medical records inadequate for determining whether patients meet pack-year requirement for lung cancer screening researchers warn.

Survival Rate Increases With Adjuvant Gefitinib in NSCLC

Survival Rate Increases With Adjuvant Gefitinib in NSCLC

Adjuvant gefitnib increases disease-free survival for patients with stage II to III non-small lung cancer.

Glucose Dependency in Squamous Cell vs Adenocarcinoma NSCLC Tumors

Glucose Dependency in Squamous Cell vs Adenocarcinoma NSCLC Tumors

Data can be used to target the development of new drugs for treating squamous cell carcinomas.

ASTRO: New Guidelines for Stereotactic Body Radiation Therapy in NSCLC

ASTRO: New Guidelines for Stereotactic Body Radiation Therapy in NSCLC

ASTRO releases guidelines on stereotactic body radiation therapy for early-stage non-small cell lung cancer

Assessing Suicide Risk in Patients With Lung Cancer

Assessing Suicide Risk in Patients With Lung Cancer

Lung cancer diagnosis raised the odds of suicide by over four times in comparison to the general population according to a study presented at annual meeting of ATS.

Does Docetaxel Plus Selumetinib in NSCLC Increase Progression-Free Survival?

Does Docetaxel Plus Selumetinib in NSCLC Increase Progression-Free Survival?

The added combination of selumetinib with docetaxel did not improve progression-free survival among patients previously treated for advanced NSCLC.

Vaccine Therapies Show Promise As Lung Cancer Tx

Vaccine Therapies Show Promise As Lung Cancer Tx

Developed in Cuba, the TG4010 and CIMAvax-EGF vaccines are undergoing clinical study in the US.

Alectinib Safe and Effective for Non-Small Cell Lung Cancer

Alectinib Safe and Effective for Non-Small Cell Lung Cancer

Two new medications may improve survival for patients with specific types of advanced non-small-cell lung cancer.

Elevated Rates of Lung Adenocarcinoma Associated With Filtered Cigarettes

Elevated Rates of Lung Adenocarcinoma Associated With Filtered Cigarettes

A report published in the Journal of the National Cancer Institute suggests that the FDA should require cigarette filters to remove the holes.

Sequental Durvalumab Ups Progression-Free Survival in NSCLC

Sequental Durvalumab Ups Progression-Free Survival in NSCLC

Participants in the phase 3 PACIFIC trial randomly received sequential treatment with either durvalumab or placebo.

Alectinib Therapy Linked To Progression-Free Survival In ALK-Positive NSCLC

Alectinib Therapy Linked To Progression-Free Survival In ALK-Positive NSCLC

Alectinib, a selective ALK inhibitor, was found to have an objective response rate of 92% among patients with ALK-positive NSCLC.

FDA Approves For Combination Pembrolizumab Plus Pemetrexed/Carboplatin Therapy For NSCLC

FDA Approves For Combination Pembrolizumab Plus Pemetrexed/Carboplatin Therapy For NSCLC

Approval was based on tumor response rate and progression-free survival data, gathered from the KEYNOTE-021 study.

FDA Grants Accelerated Approval to Brigatinib for Metastatic NSCLC

FDA Grants Accelerated Approval to Brigatinib for Metastatic NSCLC

The Food and Drug Administration (FDA) has granted accelerated approval to Alunbrig (brigatinib; ARIAD) tablets.

Page 1 of 2

Sign Up for Free e-newsletters